Hepatocellular carcinoma: Mechanisms of progression and immunotherapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hepatocellular carcinoma: Mechanisms of progression and immunotherapy
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 25, Issue 25, Pages 3151-3167
Publisher
Baishideng Publishing Group Inc.
Online
2019-07-04
DOI
10.3748/wjg.v25.i25.3151
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bazedoxifene exhibits growth suppressive activity by Targeting IL-6/GP130/STAT3 Signaling in Hepatocellular Carcinoma
- (2019) Haiyan Ma et al. CANCER SCIENCE
- Breakdown of adaptive immunotolerance induces hepatocellular carcinoma in HBsAg-tg mice
- (2019) Lu Zong et al. Nature Communications
- Low expression level of HMBOX1 in high-grade serous ovarian cancer accelerates cell proliferation by inhibiting cell apoptosis
- (2018) Yun-Liang Yu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Maintenance of stemness by miR-589-5p in hepatocellular carcinoma cells promotes chemoresistance via STAT3 signaling
- (2018) Jianting Long et al. CANCER LETTERS
- Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
- (2018) Ye Li et al. Cell Stem Cell
- IL-6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinoma
- (2018) Zi Yin et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway
- (2018) Xiao Fu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation
- (2018) Shirley Abitbol et al. JOURNAL OF HEPATOLOGY
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- HMBOX1 in hepatocytes attenuates LPS/D-GalN-induced liver injury by inhibiting macrophage infiltration and activation
- (2018) Hengli Zhao et al. MOLECULAR IMMUNOLOGY
- Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma
- (2018) Min Yu et al. MOLECULAR THERAPY
- CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges
- (2018) Stephen J Bagley et al. NEURO-ONCOLOGY
- Homeobox containing�1 inhibits liver cancer progression by promoting autophagy as well as inhibiting stemness and immune escape
- (2018) Hengli Zhao et al. ONCOLOGY REPORTS
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma
- (2018) Yusheng Cheng et al. Cell Death & Disease
- 14-3-3ζ delivered by hepatocellular carcinoma-derived exosomes impaired anti-tumor function of tumor-infiltrating T lymphocytes
- (2018) Xiaochen Wang et al. Cell Death & Disease
- Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors
- (2018) Yang Yang et al. Cell Death & Disease
- Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer
- (2018) Tian Fang et al. Nature Communications
- CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial
- (2018) Yao Wang et al. OncoImmunology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Regulation of Macrophage Activation and Polarization by HCC-Derived Exosomal lncRNA TUC339
- (2018) Xue Li et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Differential regulation of the Wnt/β-catenin pathway by hepatitis C virus recombinants expressing core from various genotypes
- (2018) Stephanie Aicher et al. Scientific Reports
- Sorafenib inhibits caspase-1 expression through suppressing TLR4/stat3/SUMO1 pathway in hepatocellular carcinoma
- (2018) Jun Li et al. CANCER BIOLOGY & THERAPY
- Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model
- (2018) Diana Llopiz et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- TLR9 agonist enhances radiofrequency ablation-induced CTL responses, leading to the potent inhibition of primary tumor growth and lung metastasis
- (2018) Aizhang Xu et al. Cellular & Molecular Immunology
- Influence of miR-520e-mediated MAPK signaling pathway on HBV replication and regulation of hepatocellular carcinoma cells via targeting EphA2
- (2018) Jing-hui Tian et al. JOURNAL OF VIRAL HEPATITIS
- Wnt–β-catenin signalling in liver development, health and disease
- (2018) Maria J. Perugorria et al. Nature Reviews Gastroenterology & Hepatology
- Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma
- (2018) Xingliang Guo et al. Frontiers in Pharmacology
- Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy
- (2017) Jingying Zhou et al. GUT
- Prospero-related homeobox 1 drives angiogenesis of hepatocellular carcinoma through selectively activating interleukin-8 expression
- (2017) Yanfeng Liu et al. HEPATOLOGY
- Virus-induced hepatocellular carcinoma with special emphasis on HBV
- (2017) Ming Wang et al. Hepatology International
- MiR-221 mediates the epithelial-mesenchymal transition of hepatocellular carcinoma by targeting AdipoR1
- (2017) Tong Li et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma
- (2017) Miao Yu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- NK3 homeobox 1 (NKX3.1) up-regulates forkhead box O1 expression in hepatocellular carcinoma and thereby suppresses tumor proliferation and invasion
- (2017) Jingyi Jiang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition
- (2017) Hong-bo Huan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Upregulation of DARS2 by HBV promotes hepatocarcinogenesis through the miR-30e-5p/MAPK/NFAT5 pathway
- (2017) Xian Qin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- miR-500a-3p promotes cancer stem cells properties via STAT3 pathway in human hepatocellular carcinoma
- (2017) Chunlin Jiang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- STAT3-blocked whole-cell hepatoma vaccine induces cellular and humoral immune response against HCC
- (2017) Qiuju Han et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models
- (2017) Zhen Lu et al. JOURNAL OF HEPATOLOGY
- Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
- (2017) Austin G. Duffy et al. JOURNAL OF HEPATOLOGY
- High expression of HOXA13 correlates with poorly differentiated hepatocellular carcinomas and modulates sorafenib response in in vitro models
- (2017) Luca Quagliata et al. LABORATORY INVESTIGATION
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Bridging to liver transplantation in HCC patients
- (2017) Dagmar Kollmann et al. LANGENBECKS ARCHIVES OF SURGERY
- Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma
- (2017) Hao-Tu Zhu et al. LIVER INTERNATIONAL
- Homeobox-containing protein 1 loss is associated with clinicopathological performance in glioma
- (2017) Ping Zhang et al. Molecular Medicine Reports
- Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches
- (2017) Gonzalo Sapisochin et al. Nature Reviews Gastroenterology & Hepatology
- Systemic Therapy for Hepatocellular Carcinoma: 2017 Update
- (2017) Masatoshi Kudo ONCOLOGY
- Nifuroxazide prompts antitumor immune response of TCL-loaded DC in mice with orthotopically-implanted hepatocarcinoma
- (2017) Tiesuo Zhao et al. ONCOLOGY REPORTS
- STAT3 deficiency prevents hepatocarcinogenesis and promotes biliary proliferation in thioacetamide-induced liver injury
- (2017) Mitsuhiko Abe et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Th17/Treg imbalance is an indicator of liver cirrhosis process and a risk factor for HCC occurrence in HBV patients
- (2017) Kun Li et al. Clinics and Research in Hepatology and Gastroenterology
- Hypoxia activates Wnt/β-catenin signaling by regulating the expression of BCL9 in human hepatocellular carcinoma
- (2017) Wei Xu et al. Scientific Reports
- Targeting blockage of STAT3 inhibits hepatitis B virus-related hepatocellular carcinoma
- (2016) Yinli Yang et al. CANCER BIOLOGY & THERAPY
- HBx mutations promote hepatoma cell migration through the Wnt/β-catenin signaling pathway
- (2016) Zhen Chen et al. CANCER SCIENCE
- Exosomes mediate hepatitis B virus (HBV) transmission and NK-cell dysfunction
- (2016) Yinli Yang et al. Cellular & Molecular Immunology
- Loss of P53 Function Activates JAK2–STAT3 Signaling to Promote Pancreatic Tumor Growth, Stroma Modification, and Gemcitabine Resistance in Mice and Is Associated With Patient Survival
- (2016) Sonja M. Wörmann et al. GASTROENTEROLOGY
- Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humansin vitro
- (2016) Quan Rao et al. HEPATOLOGY
- Octamer 4/microRNA-1246 signaling axis drives Wnt/β-catenin activation in liver cancer stem cells
- (2016) Stella Chai et al. HEPATOLOGY
- Differential expression of plasma microRNA-125b in hepatitis B virus-related liver diseases and diagnostic potential for hepatitis B virus-induced hepatocellular carcinoma
- (2016) Shanshan Chen et al. HEPATOLOGY RESEARCH
- Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis
- (2016) Wantae Kim et al. JOURNAL OF CLINICAL INVESTIGATION
- Exosomes derived from HCC cells induce sorafenib resistance in hepatocellular carcinoma both in vivo and in vitro
- (2016) Zhen Qu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Action and function of Wnt/β-catenin signaling in the progression from chronic hepatitis C to hepatocellular carcinoma
- (2016) Wenhui Wang et al. JOURNAL OF GASTROENTEROLOGY
- Hepatitis B virus-human chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122
- (2016) Hong-Wei Liang et al. JOURNAL OF HEPATOLOGY
- Hepatitis B Virus and DNA Stimulation Trigger a Rapid Innate Immune Response through NF-κB
- (2016) Masato Yoneda et al. JOURNAL OF IMMUNOLOGY
- Tumor-associated macrophage or chemokine ligand CCL17 positively regulates the tumorigenesis of hepatocellular carcinoma
- (2016) Fangyu Zhu et al. MEDICAL ONCOLOGY
- miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway
- (2016) Xuemin Liu et al. ONCOLOGY REPORTS
- Dendritic Cells and Cancer Immunity
- (2016) Alycia Gardner et al. TRENDS IN IMMUNOLOGY
- Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activation
- (2016) J-t Cheng et al. Oncogenesis
- Hepatocellular carcinoma
- (2016) Josep M. Llovet et al. Nature Reviews Disease Primers
- STAT3 Establishes an Immunosuppressive Microenvironment during the Early Stages of Breast Carcinogenesis to Promote Tumor Growth and Metastasis
- (2015) Laura M. Jones et al. CANCER RESEARCH
- -Catenin Promotes Regulatory T-cell Responses in Tumors by Inducing Vitamin A Metabolism in Dendritic Cells
- (2015) Y. Hong et al. CANCER RESEARCH
- Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs
- (2015) Mian He et al. CARCINOGENESIS
- miR-146a is directly regulated by STAT3 in human hepatocellular carcinoma cells and involved in anti-tumor immune suppression
- (2015) Xiaoxia Sun et al. CELL CYCLE
- The Long Noncoding RNA lncTCF7 Promotes Self-Renewal of Human Liver Cancer Stem Cells through Activation of Wnt Signaling
- (2015) Yanying Wang et al. Cell Stem Cell
- Recurrence of hepatocellular carcinoma after liver transplantation: an update
- (2015) Alessandra Mazzola et al. Future Oncology
- β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis
- (2015) Satdarshan Pal Monga GASTROENTEROLOGY
- Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches
- (2015) Tim F Greten et al. GUT
- Hepatitis B virus X protein activates Notch signaling by its effects on Notch1 and Notch4 in human hepatocellular carcinoma
- (2015) JUAN GAO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Advances in targeted therapies for hepatocellular carcinoma in the genomic era
- (2015) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- Immunological landscape and immunotherapy of hepatocellular carcinoma
- (2015) Jesús Prieto et al. Nature Reviews Gastroenterology & Hepatology
- PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing β-catenin expression and nuclear translocation
- (2015) Y Liu et al. ONCOGENE
- β-Catenin in dendritic cells exerts opposite functions in cross-priming and maintenance of CD8+T cells through regulation of IL-10
- (2015) Chunmei Fu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular mechanism of hepatitis B virus X protein function in hepatocarcinogenesis
- (2015) Ming Geng WORLD JOURNAL OF GASTROENTEROLOGY
- Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells
- (2015) Ronghua Wang et al. Oncotarget
- A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma
- (2015) Shan-Shan Jiang et al. Oncotarget
- TLR4 signaling promotes a COX-2/PGE2/STAT3 positive feedback loop in hepatocellular carcinoma (HCC) cells
- (2015) Ang Lin et al. OncoImmunology
- Phosphorothioate-modified CpG oligodeoxynucleotide (CpG ODN) induces apoptosis of human hepatocellular carcinoma cells independent of TLR9
- (2014) Yuyi Zhang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phosphorothioate modification of the TLR9 ligand CpG ODN inhibits poly(I:C)-induced apoptosis of hepatocellular carcinoma by entry blockade
- (2014) Yuyi Zhang et al. CANCER LETTERS
- Restoration of miR-193b sensitizes Hepatitis B virus-associated hepatocellular carcinoma to sorafenib
- (2014) Kai Mao et al. CANCER LETTERS
- -Catenin Activation in a Novel Liver Progenitor Cell Type Is Sufficient to Cause Hepatocellular Carcinoma and Hepatoblastoma
- (2014) S. Mokkapati et al. CANCER RESEARCH
- NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma
- (2014) Cheng Sun et al. Cellular & Molecular Immunology
- Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma
- (2014) H. Gao et al. CLINICAL CANCER RESEARCH
- Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cells
- (2014) Shanshan Wan et al. GASTROENTEROLOGY
- Integration of tumour and viral genomic characterisations in HBV-related hepatocellular carcinomas
- (2014) Giuliana Amaddeo et al. GUT
- hIL-15 gene-modified human natural killer cells (NKL-IL15) augments the anti-human hepatocellular carcinoma effect in vivo
- (2014) Wen Jiang et al. IMMUNOBIOLOGY
- Macrophage-secreted IL-8 induces epithelial-mesenchymal transition in hepatocellular carcinoma cells by activating the JAK2/STAT3/Snail pathway
- (2014) XIU-TAO FU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- NK Cells Are the Crucial Antitumor Mediators When STAT3-Mediated Immunosuppression Is Blocked in Hepatocellular Carcinoma
- (2014) Qiangjun Sui et al. JOURNAL OF IMMUNOLOGY
- HOX genes and their role in the development of human cancers
- (2014) Seema Bhatlekar et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- HOXA7 stimulates human hepatocellular carcinoma proliferation through cyclin E1/CDK2
- (2014) YUEHUI LI et al. ONCOLOGY REPORTS
- Overexpression of HOXA13 as a Potential Marker for Diagnosis and Poor Prognosis of Hepatocellular Carcinoma
- (2014) Ting-Ting Pan et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- MicroRNAs Associated With HBV Infection And HBV-related HCC
- (2014) Kun-Lin Xie et al. Theranostics
- The Efficacy of Cytokine-Induced Killer Cell Infusion as an Adjuvant Therapy for Postoperative Hepatocellular Carcinoma Patients
- (2013) Ke Pan et al. ANNALS OF SURGICAL ONCOLOGY
- CTLA-4 and PD-1/PD-L1 Blockade: New Immunotherapeutic Modalities with Durable Clinical Benefit in Melanoma Patients
- (2013) P. A. Ott et al. CLINICAL CANCER RESEARCH
- hIFN-α gene modification augments human natural killer cell line anti-human hepatocellular carcinoma function
- (2013) W Jiang et al. GENE THERAPY
- Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients
- (2013) Luca Quagliata et al. HEPATOLOGY
- Epigenetic silencing ofSFRP1andSFRP5by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway
- (2013) Qing Xie et al. INTERNATIONAL JOURNAL OF CANCER
- A randomized phase II study of autologous cytokine-induced killer cells in treatment of hepatocelluar carcinoma
- (2013) Xiaozhou Yu et al. JOURNAL OF CLINICAL IMMUNOLOGY
- A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
- (2013) Bruno Sangro et al. JOURNAL OF HEPATOLOGY
- -Catenin mediates tumor-induced immunosuppression by inhibiting cross-priming of CD8+ T cells
- (2013) X. Liang et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Targeting Blockage of STAT3 in Hepatocellular Carcinoma Cells Augments NK Cell Functions via Reverse Hepatocellular Carcinoma-Induced Immune Suppression
- (2013) X. Sun et al. MOLECULAR CANCER THERAPEUTICS
- CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
- (2013) R. J. Brentjens et al. Science Translational Medicine
- Cellular and molecular mechanisms of hepatocellular carcinoma: an update
- (2012) Rajagopal N. Aravalli et al. ARCHIVES OF TOXICOLOGY
- TGF-β-miR-34a-CCL22 Signaling-Induced Treg Cell Recruitment Promotes Venous Metastases of HBV-Positive Hepatocellular Carcinoma
- (2012) Pengyuan Yang et al. CANCER CELL
- Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
- (2012) Dianne H. Dapito et al. CANCER CELL
- miR-30c-1* promotes natural killer cell cytotoxicity against human hepatoma cells by targeting the transcription factor HMBOX1
- (2012) Jiuyu Gong et al. CANCER SCIENCE
- Wnt/β-Catenin Signaling and Disease
- (2012) Hans Clevers et al. CELL
- Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma
- (2012) FUJIMASA TADA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Anticancer Drugs Cause Release of Exosomes with Heat Shock Proteins from Human Hepatocellular Carcinoma Cells That Elicit Effective Natural Killer Cell Antitumor Responsesin Vitro
- (2012) Li-Hong Lv et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Immunotherapy by autologous dendritic cell vaccine in patients with advanced HCC
- (2012) Mervat El Ansary et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Inflammation and Cancer: A Comparative View
- (2011) Wallace B. Morrison JOURNAL OF VETERINARY INTERNAL MEDICINE
- The homeobox gene HLXB9 is upregulated in a morphological subset of poorly differentiated hepatocellular carcinoma
- (2011) Ludwig Wilkens et al. VIRCHOWS ARCHIV
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Serum microRNA Profiles Serve as Novel Biomarkers for HBV Infection and Diagnosis of HBV-Positive Hepatocarcinoma
- (2010) L.-M. Li et al. CANCER RESEARCH
- Recombinant Expression of a Novel Human Transcriptional Repressor HMBOX1 and Preparation of Anti-HMBOX1 Monoclonal Antibody
- (2010) Jun Dai et al. Cellular & Molecular Immunology
- Toll-like receptors 2/4 agonists: a potential strategy for preventing invasion and metastasis of hepatocellular carcinoma
- (2010) P. Yu et al. GUT
- Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis
- (2010) Dipali Sharma et al. HEPATOLOGY
- The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function
- (2010) Bijan Raziorrouh et al. HEPATOLOGY
- Vaccine Adjuvants: Putting Innate Immunity to Work
- (2010) Robert L. Coffman et al. IMMUNITY
- Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B
- (2010) Eric T.T.L. Tjwa et al. JOURNAL OF HEPATOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvants for cancer vaccines
- (2010) Thomas W. Dubensky et al. SEMINARS IN IMMUNOLOGY
- Specific mutations in the enhancer II/core promoter/precore regions of hepatitis B virus subgenotype C2 in Korean patients with hepatocellular carcinoma
- (2009) Ja Kyung Kim et al. JOURNAL OF MEDICAL VIROLOGY
- Glypican 3 Expression in Human Nonneoplastic, Preneoplastic, and Neoplastic Tissues
- (2008) Daniel Baumhoer et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Immunotherapy of hepatocellular carcinoma with a vaccine based on xenogeneic homologous α fetoprotein in mice
- (2008) Wei Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Growth inhibition of human hepatocellular carcinoma cells by blocking STAT3 activation with decoy-ODN
- (2008) Xiaoxia Sun et al. CANCER LETTERS
- Functional characterization of interleukin-15 gene transduction into the human natural killer cell line NKL
- (2008) W. Jiang et al. CYTOTHERAPY
- Hepatitis B virus X protein affects S phase progression leading to chromosome segregation defects by binding to damaged DNA binding protein 1
- (2008) Silvia Martin-Lluesma et al. HEPATOLOGY
- Characterization of the innate immune signalling pathways in hepatocyte cell lines
- (2008) S. Preiss et al. JOURNAL OF VIRAL HEPATITIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now